NUWE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Stats
Today's Volume	5.27M
Average Volume	5.72M
Market Cap	4.68M
EPS	US12542Q700 ( 2024-05-14 )
Next earnings date	( US12542Q70-0.200 ) 2024-08-06
Last Dividend	US12542Q700 ( N/A )
Next Dividend	US12542Q700 ( N/A )
P/E	-0.0400
ATR14	US12542Q700.00200 (0.77%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Mccormick Michael Kendrick	Buy	20 836	Nonstatutory Stock Option (right to buy)
2024-01-02	Mcdonald David	Buy	11 365	Nonstatutory Stock Option (right to buy)
2024-01-02	Feldshon Archelle Georgiou	Buy	11 365	Nonstatutory Stock Option (right to buy)
2023-11-01	Mcdonald David	Buy	0
2023-11-01	Feldshon Archelle Georgiou	Buy	0

INSIDER POWER
97.84
Last 90 transactions
Buy: 3 285 386 \| Sell: 12 287

Volume Correlation

Long: -0.21 (neutral)

Short: -0.16 (neutral)

Signal:(52.477) Neutral

Nuwellis, Inc. Correlation

10 Most Positive Correlations
SHLS	0.937
LPRO	0.903
IART	0.902
GDYN	0.898
NVEE	0.897
SHC	0.894
TXG	0.89
DH	0.89
SGRY	0.888
RPD	0.888

10 Most Negative Correlations
REFR	-0.883
IVCB	-0.86
JAN	-0.86
KEQU	-0.856
VITL	-0.854
AEYE	-0.848
AVDL	-0.846
RZLT	-0.845
PPTA	-0.844
SHIP	-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nuwellis, Inc. Correlation - Currency/Commodity

0.00
( neutral )

0.19
( neutral )

0.00
( neutral )

0.05
( neutral )

Nuwellis, Inc. Financials

Annual	2023
Revenue:	US12542Q708.86M
Gross Profit:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2023
Revenue:	US12542Q708.86M
Gross Profit:	US12542Q704.98M (56.22 %)
EPS:	US12542Q70-10.29

FY	2022
Revenue:	US12542Q708.54M
Gross Profit:	US12542Q704.76M (55.66 %)
EPS:	US12542Q70-83.48

FY	2021
Revenue:	US12542Q707.92M
Gross Profit:	US12542Q704.49M (56.70 %)
EPS:	US12542Q70-285.73

Financial Reports:

No articles found.

Nuwellis, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nuwellis, Inc.

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.